JP2024531188A5 - - Google Patents

Info

Publication number
JP2024531188A5
JP2024531188A5 JP2024508384A JP2024508384A JP2024531188A5 JP 2024531188 A5 JP2024531188 A5 JP 2024531188A5 JP 2024508384 A JP2024508384 A JP 2024508384A JP 2024508384 A JP2024508384 A JP 2024508384A JP 2024531188 A5 JP2024531188 A5 JP 2024531188A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
use according
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024508384A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024531188A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/040115 external-priority patent/WO2023018904A1/en
Publication of JP2024531188A publication Critical patent/JP2024531188A/ja
Publication of JP2024531188A5 publication Critical patent/JP2024531188A5/ja
Pending legal-status Critical Current

Links

JP2024508384A 2021-08-11 2022-08-11 重水素化jak阻害剤による脱毛障害の治療 Pending JP2024531188A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163232107P 2021-08-11 2021-08-11
US63/232,107 2021-08-11
PCT/US2022/040115 WO2023018904A1 (en) 2021-08-11 2022-08-11 Treatment of hair loss disorders with deuterated jak inhibitors

Publications (2)

Publication Number Publication Date
JP2024531188A JP2024531188A (ja) 2024-08-29
JP2024531188A5 true JP2024531188A5 (cg-RX-API-DMAC7.html) 2025-10-15

Family

ID=83151848

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508384A Pending JP2024531188A (ja) 2021-08-11 2022-08-11 重水素化jak阻害剤による脱毛障害の治療

Country Status (7)

Country Link
US (2) US12285432B2 (cg-RX-API-DMAC7.html)
EP (1) EP4384175A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024531188A (cg-RX-API-DMAC7.html)
CN (1) CN118159272A (cg-RX-API-DMAC7.html)
AU (1) AU2022328272A1 (cg-RX-API-DMAC7.html)
CA (1) CA3228505A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023018904A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10561659B2 (en) * 2016-05-04 2020-02-18 Concert Pharmaceuticals, Inc. Treatment of hair loss disorders with deuterated JAK inhibitors
US20230390292A1 (en) * 2020-10-28 2023-12-07 Sun Pharmaceutical Industries, Inc. Regimens for the treatment of hair loss disorders with deuterated jak inhibitors
WO2023018904A1 (en) 2021-08-11 2023-02-16 Concert Pharmaceuticals, Inc. Treatment of hair loss disorders with deuterated jak inhibitors
US12364699B2 (en) 2023-10-10 2025-07-22 Sun Pharmaceuticals Industries, Inc. Method of treating hair loss disorders
US20260027120A1 (en) * 2024-07-25 2026-01-29 Sun Pharmaceutical Industries, Inc. Methods of treatment of jak inhibition responsive conditions with deuterated jak inhibitors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9925962D0 (en) 1999-11-02 1999-12-29 Novartis Ag Organic compounds
CZ20033211A3 (cs) 2001-05-03 2004-09-15 F. Hoffmann-La Roche Ag Farmaceutická léková forma amorfního nelfinavir mesylátu
WO2006039237A1 (en) 2004-09-29 2006-04-13 Cordis Corporation Pharmaceutical dosage forms of stable amorphous rapamycin like compounds
WO2007065167A1 (en) * 2005-12-02 2007-06-07 The Johns Hopkins University Use of high-dose oxazaphosphorine drugs for treating immune disorders
HUE028588T2 (hu) 2005-12-13 2016-12-28 Incyte Holdings Corp Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok
LT1993360T (lt) 2005-12-28 2017-06-12 Vertex Pharmaceuticals Incorporated N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma
CL2008001709A1 (es) 2007-06-13 2008-11-03 Incyte Corp Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
WO2010083283A2 (en) 2009-01-15 2010-07-22 Incyte Corporation Processes for preparing jak inhibitors and related intermediate compounds
PT2635299T (pt) 2010-11-02 2019-10-14 Univ Columbia Métodos de tratamento de distúrbios de perda de cabelo
US9198911B2 (en) 2010-11-02 2015-12-01 The Trustees Of Columbia University In The City Of New York Methods for treating hair loss disorders
DK2830662T3 (da) 2012-03-29 2019-01-02 Univ Columbia Fremgangsmåder til behandlng af hårtabsforstyrrelser
EP3450434B1 (en) 2012-06-15 2021-02-24 CoNCERT Pharmaceuticals, Inc. Deuterated derivatives of ruxolitinib
KR102242077B1 (ko) 2012-11-15 2021-04-20 인사이트 홀딩스 코포레이션 룩솔리티니브의 서방성 제형
MX2016010213A (es) 2014-02-07 2017-04-13 Auspex Pharmaceuticals Inc Formulaciones farmaceuticas novedosas.
US10561659B2 (en) * 2016-05-04 2020-02-18 Concert Pharmaceuticals, Inc. Treatment of hair loss disorders with deuterated JAK inhibitors
EP3921318A1 (en) 2019-02-06 2021-12-15 Concert Pharmaceuticals Inc. Process for preparing enantiomerically enriched jak inhibitors
WO2023018904A1 (en) 2021-08-11 2023-02-16 Concert Pharmaceuticals, Inc. Treatment of hair loss disorders with deuterated jak inhibitors

Similar Documents

Publication Publication Date Title
JP2022546471A5 (cg-RX-API-DMAC7.html)
CN109890366B (zh) 治疗心血管疾病的组合药物及其制备和使用方法
JP2018510178A5 (cg-RX-API-DMAC7.html)
JP2009514874A5 (cg-RX-API-DMAC7.html)
EA020193B1 (ru) Комбинации, включающие метотрексат и ингибиторы дигидрооротатдегидрогеназы (dhodh)
JP2019516684A5 (cg-RX-API-DMAC7.html)
WO2022218958A1 (en) Combination comprising everolimus and amcenestrant
JP2024507810A5 (cg-RX-API-DMAC7.html)
JP2017128610A (ja) 併用als療法
JP2023553253A5 (cg-RX-API-DMAC7.html)
EP4494701A3 (en) New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
JP4786127B2 (ja) 色素沈着改善治療薬
JP2023548429A5 (cg-RX-API-DMAC7.html)
JP2016505050A5 (cg-RX-API-DMAC7.html)
WO2017148129A1 (zh) 一种用于治疗恶病质的药物组合物及其应用
US11571411B2 (en) Use of a bisamide derivative of malonic acid for treating allergic and other diseases in humans and animals
JP2019509309A5 (cg-RX-API-DMAC7.html)
JP2022177119A5 (cg-RX-API-DMAC7.html)
JP2006508118A5 (cg-RX-API-DMAC7.html)
JP2024084670A5 (cg-RX-API-DMAC7.html)
JP2021091608A5 (cg-RX-API-DMAC7.html)
KR101633292B1 (ko) 용법이 개선된 엔테카비어를 함유하는 약학적 조성물
CN118252833A (zh) Vofopitant用于治疗肺纤维化的用途
JP6420923B1 (ja) 医薬
CA2684938A1 (en) Dihydropyridine derivative for treating cancer or a pre-cancerous condition and other conditions